SCHEMBL7654186

SCHEMBL7654186

CCOC(C)OCC.O=CCc1ccccc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
LMNA P02545 2/20 0.38
IDO1 P14902 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
NFKB1 P19838 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BLM P54132 1/20 0.35
TAAR1 Q96RJ0 3/20 0.34
RIPK1 Q13546 1/20 0.33
EPHX2 P34913 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GABRA1 P14867 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL10990240 0.94 TSHR (0.37) TSHRLMNAIDO1CYP1A2CYP2D6
SCHEMBL2478901 0.84 ALDH1A1 (0.40) TSHRLMNAIDO1CYP1A2CYP2D6
SCHEMBL29566515 0.81 TAAR1 (0.46) TSHRLMNAIDO1CYP1A2CYP2D6
SCHEMBL166137 0.81 TAAR1 (0.46) TSHRLMNAIDO1CYP1A2CYP2D6
SCHEMBL7535391 0.80 IDO1 (0.48) TSHRLMNAIDO1CYP1A2CYP2D6
SCHEMBL7654309 0.79 ATP4A (0.36) LMNAALDH1A1MAPTRAB9ASMN1; SMN2
Phenylacetaldehyde SCHEMBL452558 0.78 LMNA (0.44) TSHRLMNAHTTSMN1; SMN2TAAR1
SCHEMBL3905460 0.78 LMNA (0.40) TSHRLMNAALDH1A1HTTSMN1; SMN2
Phenylacetaldehyde SCHEMBL1412189 0.76 LMNA (0.41) TSHRLMNAHTTSMN1; SMN2TAAR1
SCHEMBL4918898 0.75 LMNA (0.55) TSHRLMNAMAPTL3MBTL1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365616-B1 TRANSPLANT REJECTION SENTRON MEDICAL, INC. 2002-04-02 US disclosed
EP-1112072-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES Sentron Medical, Inc. (US) 2001-07-04 EP disclosed
WO-2000012175-A2 METHIMAZOLE DERIVATIVES AND TAUTOMERIC CYCLIC THIONES TO TREAT AUTOIMMUNE DISEASES SENTRON MEDICAL, INC. (US) 2000-03-09 WO disclosed